500420
Torrent Pharmaceuticals Ltd
BSELast Traded Price
₹4635.00
-44.00 (-0.94%)
Open
₹4653.15
High
₹4663.60
Low
₹4604.40
Prev Close
₹4679.00
Industry
Healthcare
Market Cap
1,76,294.20 Cr
Filing History
Recent corporate announcements and filings for 500420
Business Update
Neutral
2026-10-09 11:43
Concall Schedule
Concall Date: 23rd October, 2026
Concall Time: 05:30 P.M.
Business Update
Positive
2026-10-07 19:36
- India Ratings and Research Private Limited has affirmed the credit rating at IND AA+ and revised the outlook from stable to positive for the Company's existing banking facilities, issuer rating, and Non-Convertible Debentures.
- Affirmed and assigned the credit rating for the existing and proposed Commercial paper at IND A1+.
Governance
Neutral
2026-10-06 18:55
- Board meeting scheduled on Friday, 23-Oct-2026.
- Agenda includes consideration and approval of standalone audited and consolidated unaudited financial results for the quarter and half year ended 30-Sep-2026.
Business Update
Positive
2026-09-28 12:01
Torrent Pharmaceuticals executed an Amendment Agreement to enhance its investment in Torrent Urja 27 Private Limited from INR 7,91,93,400 to INR 11,87,90,100.
- The increased investment is due to an expansion in project capacity for setting up a captive hybrid (Solar + Wind) power project in Gujarat.
- The company will acquire a 26% stake through a cash consideration of INR 11.88 crores.
- The acquisition is expected to be completed within 18 to 21 months.
Routine
Neutral
2026-09-28 11:29
- Trading window for dealing in securities stands closed from 1st October, 2026.
- Closure applies to Designated Persons in relation to financial results for the quarter ended 30th September, 2026.
- Re-opens 48 hours after the financial results are submitted to the stock exchanges.
Business Update
Neutral
2026-09-10 21:27
- Intimation of schedule of Investors' Meet
- Meetings include:
- 17-Sep-26: Jefferies India forum 2026 in Gurgaon (Group and one on one)
- 18-Sep-26: Kotak Healthcare Forum 2026 in Mumbai (Group and one on one)
- 21-Sep-26: JP Morgan India Conference in Mumbai (Group and one on one)
Governance
Neutral
2026-09-07 19:20
- Torrent Pharmaceuticals announced the results of the Postal Ballot on September 7, 2026.
- The Special Resolution for the appointment of Shanti Ekambaram as an Independent Director of the Company was passed with 99.98% votes in favour.
Governance
Positive
2026-09-07 19:17
- Shareholders of Torrent Pharmaceuticals Limited approved the appointment of Shanti Ekambaram as an Independent Director via postal ballot. The resolution passed with 99.98% votes in favour, with results announced on September 07, 2026.